---
# Documentation: https://wowchemy.com/docs/managing-content/

title: "TKDN di farmasi"
subtitle: ""
summary: ""
authors: []
tags: []
categories: []
date: 2022-09-06T20:02:49+07:00
lastmod: 2022-09-06T20:02:49+07:00
featured: false
draft: false

# Featured image
# To use, add an image named `featured.jpg/png` to your page's folder.
# Focal points: Smart, Center, TopLeft, Top, TopRight, Left, Right, BottomLeft, Bottom, BottomRight.
image:
  caption: ""
  focal_point: ""
  preview_only: false

# Projects (optional).
#   Associate this post with one or more of your projects.
#   Simply enter your project's folder or file name without extension.
#   E.g. `projects = ["internal-project"]` references `content/project/deep-learning/index.md`.
#   Otherwise, set `projects = []`.
projects: []
---

## List peraturan terkait industri farmasi

| no | aturan | tentang | note |
| -- | ------ | ------- | ---- |
| 1 | UU 13/2016 | Paten | pasal 20 ayat 1 |
| 2 | UU 19/2003 | BUMN | BUMN boleh collab penelitian. |
| 3 | PMK 153/2020 | Super Deduction Tax | R&D dipotong dari perhitungan pajak |
| 4 | Permenkes 1010/2008 | Semua obat beredar wajib diproduksi di dalam negeri |
| 5 | Permenperin 16/2020 | Penghitungan kandungan lokal untuk produk farmasi |

Produsen dalam negeri menguasai [95% pangsa pasar](https://nasional.sindonews.com/read/227038/18/mampukah-uu-ciptaker-dorong-inovasi-farmasi-1605010262). low-value added, low margin, generic. China's API is too big, even India and EU producers [exit](https://www.thejakartapost.com/academia/2020/06/17/local-content-regulation-for-pharma-not-the-panacea.html).

China's doubling down on supply side policies while neglecting its demand side will ensure high exports. It will be extremely hard to lure them in.

Cek ICIO utk value added.

domestic market is small. 1% of global drug market.